The Experts below are selected from a list of 9 Experts worldwide ranked by ideXlab platform
Alain Gabriel Chabaud - One of the best experts on this subject based on the ideXlab platform.
-
Nématodes Trichostrongyloidea Parasites de Microchiroptères
'EDP Sciences', 2017Co-Authors: M.-c. Durette-desset, Alain Gabriel ChabaudAbstract:1. a) Liste des Nématodes, parasites de Chiroptères européens récoltés par le Pr Aellen : compléments à l’étude morphologique de Molinostrongylus alatus, M. panousei, M. skrjabini ; description de M. aelleni n. sp. b) Description de M. richardae n. sp., M. benexae n. sp. et M. bauchoti n. sp. parasites de Molossidae malgaches. c) Description de M. colleyi n. sp. et M. owyangi n. sp., parasites de Vespertilioninae malais, et d’Allintoschius dunni n. sp., trouvé chez Myotis mystacinus en Malaisie et Pipistrellus nanus en Afrique. 2. D’après le synlophe, les 17 espèces du genre Molinostrongylus semblent se répartir en cinq groupes d’espèces, chacun d’eux étant assez caractéristique d’un genre déterminé de Chiroptères. 3. La composition de la nématofaune (Trichostrongyloidea) des Chiroptères est analysée, ainsi que ses rapports avec les Trichostrongyloidea d’autres Mammifères (Tupaiidae, Pholidotes, Primates, Sciuridés). Six groupes sont individualisés, constituant deux ensembles bien distincts : genre Strongylacantha, d’une part ; 12 genres plus ou moins directement issus des Molineinae, d’autre part. 4. Les trois pointes de l’extrémité caudale des femelles, qui définissent actuellement les Anoplostrongylinae par rapport aux Molineinae, se révèlent un caractère insuffisant. Les deux sous-familles forment un ensemble complexe, qui ne pourra être interprété qu’en tenant compte également de l’évolution du synlophe et de celle des bourses caudales des mâles
Tetsufumi Koga - One of the best experts on this subject based on the ideXlab platform.
-
in vitro and in vivo antibacterial activity of plaunotol a cytoprotective antiulcer agent against helicobacter pylori
Journal of Antimicrobial Chemotherapy, 1996Co-Authors: Tetsufumi Koga, Harumi Kawada, Yukio Utsui, Haruki Domon, Chika Ishii, Hiroshi YasudaAbstract:Recently, some antiulcer agents have been reported to have antibacterial activity against Helicobacter pylori, which is highly associated with gastritis and peptic ulcers. In-vitro and in-vivo activity of plaunotol, a cytoprotective antiulcer agent, against H. pylori was investigated. Antibacterial activity of plaunotol against a standard strain (NCTC 11637) and 14 clinical isolates was compared with those of other cytoprotective antiulcer agents : Benexate, sofalcone, teprenone, cetraxate, and gefarnate, by an agar dilution method. The MIC 50 and MIC 90 of plaunotol against 15 strains were 6.25 and 12.5 mg/L, respectively, making it the most potent of the cytoprotective antiulcer agents. The bactericidal effect of plaunotol was investigated using an in-vitro killing assay. Plaunotol at concentrations of more than 6 mg/L induced a rapid reduction of culture turbidity, with an extensive loss of viability, within 30 min. Observation by scanning electron microscopy revealed that plaunotol caused autolysis and treated cells were deformed. In-vivo activity of plaunotol against H. pylori was examined in a nude mouse gastritis model. Plaunotol significantly decreased the number of H. pylori in the stomach of nude mice. In addition, the antiulcer agent enhanced the antibacterial activity of amoxycillin or clarithromycin in the infection model.
Harumi Kawada - One of the best experts on this subject based on the ideXlab platform.
-
in vitro and in vivo antibacterial activity of plaunotol a cytoprotective antiulcer agent against helicobacter pylori
Journal of Antimicrobial Chemotherapy, 1996Co-Authors: Tetsufumi Koga, Harumi Kawada, Yukio Utsui, Haruki Domon, Chika Ishii, Hiroshi YasudaAbstract:Recently, some antiulcer agents have been reported to have antibacterial activity against Helicobacter pylori, which is highly associated with gastritis and peptic ulcers. In-vitro and in-vivo activity of plaunotol, a cytoprotective antiulcer agent, against H. pylori was investigated. Antibacterial activity of plaunotol against a standard strain (NCTC 11637) and 14 clinical isolates was compared with those of other cytoprotective antiulcer agents : Benexate, sofalcone, teprenone, cetraxate, and gefarnate, by an agar dilution method. The MIC 50 and MIC 90 of plaunotol against 15 strains were 6.25 and 12.5 mg/L, respectively, making it the most potent of the cytoprotective antiulcer agents. The bactericidal effect of plaunotol was investigated using an in-vitro killing assay. Plaunotol at concentrations of more than 6 mg/L induced a rapid reduction of culture turbidity, with an extensive loss of viability, within 30 min. Observation by scanning electron microscopy revealed that plaunotol caused autolysis and treated cells were deformed. In-vivo activity of plaunotol against H. pylori was examined in a nude mouse gastritis model. Plaunotol significantly decreased the number of H. pylori in the stomach of nude mice. In addition, the antiulcer agent enhanced the antibacterial activity of amoxycillin or clarithromycin in the infection model.
Yukio Utsui - One of the best experts on this subject based on the ideXlab platform.
-
in vitro and in vivo antibacterial activity of plaunotol a cytoprotective antiulcer agent against helicobacter pylori
Journal of Antimicrobial Chemotherapy, 1996Co-Authors: Tetsufumi Koga, Harumi Kawada, Yukio Utsui, Haruki Domon, Chika Ishii, Hiroshi YasudaAbstract:Recently, some antiulcer agents have been reported to have antibacterial activity against Helicobacter pylori, which is highly associated with gastritis and peptic ulcers. In-vitro and in-vivo activity of plaunotol, a cytoprotective antiulcer agent, against H. pylori was investigated. Antibacterial activity of plaunotol against a standard strain (NCTC 11637) and 14 clinical isolates was compared with those of other cytoprotective antiulcer agents : Benexate, sofalcone, teprenone, cetraxate, and gefarnate, by an agar dilution method. The MIC 50 and MIC 90 of plaunotol against 15 strains were 6.25 and 12.5 mg/L, respectively, making it the most potent of the cytoprotective antiulcer agents. The bactericidal effect of plaunotol was investigated using an in-vitro killing assay. Plaunotol at concentrations of more than 6 mg/L induced a rapid reduction of culture turbidity, with an extensive loss of viability, within 30 min. Observation by scanning electron microscopy revealed that plaunotol caused autolysis and treated cells were deformed. In-vivo activity of plaunotol against H. pylori was examined in a nude mouse gastritis model. Plaunotol significantly decreased the number of H. pylori in the stomach of nude mice. In addition, the antiulcer agent enhanced the antibacterial activity of amoxycillin or clarithromycin in the infection model.
Haruki Domon - One of the best experts on this subject based on the ideXlab platform.
-
in vitro and in vivo antibacterial activity of plaunotol a cytoprotective antiulcer agent against helicobacter pylori
Journal of Antimicrobial Chemotherapy, 1996Co-Authors: Tetsufumi Koga, Harumi Kawada, Yukio Utsui, Haruki Domon, Chika Ishii, Hiroshi YasudaAbstract:Recently, some antiulcer agents have been reported to have antibacterial activity against Helicobacter pylori, which is highly associated with gastritis and peptic ulcers. In-vitro and in-vivo activity of plaunotol, a cytoprotective antiulcer agent, against H. pylori was investigated. Antibacterial activity of plaunotol against a standard strain (NCTC 11637) and 14 clinical isolates was compared with those of other cytoprotective antiulcer agents : Benexate, sofalcone, teprenone, cetraxate, and gefarnate, by an agar dilution method. The MIC 50 and MIC 90 of plaunotol against 15 strains were 6.25 and 12.5 mg/L, respectively, making it the most potent of the cytoprotective antiulcer agents. The bactericidal effect of plaunotol was investigated using an in-vitro killing assay. Plaunotol at concentrations of more than 6 mg/L induced a rapid reduction of culture turbidity, with an extensive loss of viability, within 30 min. Observation by scanning electron microscopy revealed that plaunotol caused autolysis and treated cells were deformed. In-vivo activity of plaunotol against H. pylori was examined in a nude mouse gastritis model. Plaunotol significantly decreased the number of H. pylori in the stomach of nude mice. In addition, the antiulcer agent enhanced the antibacterial activity of amoxycillin or clarithromycin in the infection model.